Science
Mechanism of Action
This synthetic peptide functions as a biomimetic of Transforming Growth Factor (TGF-β), initiating specific signaling pathways within the skin's cellular matrix. This crucial interaction stimulates the increased production of essential extracellular matrix (ECM) proteins, specifically type I procollagen and fibronectin. The upregulation of these proteins is fundamental for rebuilding skin architecture, which manifests as enhanced firmness, a reduction in the appearance of fine lines and wrinkles, and the maintenance of dermal thickness. It also contributes to anti-aging protection against environmental stressors, including UV irradiation.
Research
Clinical Evidence
High confidenceN/A
Key findings
- 01 Both in vitro and in vivo research consistently demonstrates that Myristoyl Tetrapeptide-6 significantly boosts the expression of type I procollagen and fibronectin. This action directly contributes to a visible reduction in fine lines and wrinkles, while simultaneously maintaining the crucial thickness of the dermis, leading to enhanced skin firmness.
Transparency
Dusting Analysis
The Formula
Formulation
Stability
This ingredient is reported to exhibit stability across a broad pH range, with one supplier noting 'not applicable' for optimal pH. For optimal storage, it remains stable at 2-8°C when protected from light, with long-term preservation recommended at -20°C to -15°C.
Safety
Safety Profile
Suppliers affirm the absence of heavy metals and report no observed skin or eye irritation, suggesting a favorable safety profile for topical application.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Myristoyl Tetrapeptide-6 is a valuable peptide for advanced skincare formulations, effectively targeting multiple signs of aging through proven collagen and fibronectin synthesis, suitable for all skin types with a low irritation risk.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources